Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Invested Capital: 2010-2025

Historic Return on Invested Capital for Gyre Therapeutics (GYRE) over the last 1 years, with Sep 2025 value amounting to 0.06%.

  • Gyre Therapeutics' Return on Invested Capital was N/A to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year change of. This contributed to the annual value of 0.28% for FY2024, which is N/A change from last year.
  • Gyre Therapeutics' Return on Invested Capital amounted to 0.06% in Q3 2025, which was up 19.56% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Return on Invested Capital ranged from a high of 0.97% in Q1 2023 and a low of 0.05% during Q2 2025.
  • Its 3-year average for Return on Invested Capital is 0.26%, with a median of 0.07% in 2025.